Business Wire - October 15, 2009
ATLANTA - Vystar Corporation and Alatech Healthcare, LLC introduce the new Envy(TM) male latex condom made with Vytex(R) Natural Rubber Latex (NRL), an ultralow protein latex material with significantly reduced levels of antigenic proteins that can cause latex allergies.
The Envy launch coincides with the Atlanta AIDS Walk on Oct. 18, where thousands of participants will join in a walk and 5K run to support AID Atlanta. Approximately 2,000 condom samples will be distributed to participants. Vystar and Alatech are also providing 10,000 condoms plus $5,000 that will benefit AID Atlanta and several other regional service organizations. These include AID Gwinnett, AIDS Alliance for Faith and Health, AIDS Research Consortium of Atlanta, Aniz, Home But Not Alone, Jerusalem House, Open Hand and Positive Impact.
The Envy condom retains all the positive qualities of a latex condom û including barrier protection, tensile strength, tactile sensitivity, elasticity, comfort and fit. Moreover, Vytex NRL is an all-natural latex material that is biodegradable and odor-free.
Vystar Corp. CEO William Doyle said, "After years of refining our natural raw material and creating an ultralow protein, superior quality latex, we are excited to introduce the first product made with Vytex NRL. We are proud to sponsor AID Atlanta's annual AIDS Walk and support several metro area outreach programs for HIV/AIDS. The new Envy condom provides an excellent latex option for consumers."
Tracy Elliott, AID Atlanta executive director, said, "We are grateful to Vystar and Alatech for their generous contribution and are pleased to have the support of Southeast-based companies."
Envy is the only male latex condom on the market with an ultralow level of antigenic protein of less than two micrograms/dm<2>. This significantly reduces the risk of individuals developing latex allergies and decreases the likelihood of skin irritations from condom use. According to the American Latex Allergy Association, up to eight percent of the general population and approximately 17 percent of healthcare workers in the U.S. experience allergies or sensitivities to traditional latex. Additionally, Envy is one of the few condoms manufactured in the U.S. More information is available at www.envycondoms.com.
Alatech President & CEO Lawrence Povlacs said, "Alatech is thrilled to partner with Vystar in launching a new line of eco-friendly, natural latex condoms for national distribution."
About Vystar Corporation
Based in Duluth, Ga., Vystar Corporation (OTC BB: VYST.OB) is the exclusive creator of Vytex(R) Natural Rubber Latex (NRL). Vytex NRL is a patented, all-natural raw material that significantly reduces antigenic proteins found in natural rubber latex and can be used in over 40,000 products. Vystar holds two U.S. patents, an additional pending application, and multiple international patent filings for Vytex NRL technology. In 2007, Vystar was named a Top 10 Innovative Technology Company in Georgia by the Technology Association of Georgia (TAG). For more information, visit www.vytex.com.
About Alatech Healthcare, LLC
Based in Eufaula, Ala., Alatech Healthcare, LLC is a leading manufacturer and supplier of condoms and latex gloves. For more information, visit www.alatechhealthcare.com
Forward-looking Statements: Certain statements in this document are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from those included in these statements due to a variety of factors. More information about these factors is contained in Vystar's filings with the Securities and Exchange Commission.
Contacts
For Vystar Corporation
Cookerly Public Relations
Ada Hatzios, 404-816-2037
ada@cookerly.com
091015
BW091023
Copyright © 2009 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .